https://pharminent.com/parkinsons-drug-from-biogen-denali-comes-up-short/ 2026-05-22T16:17:05Z Pharminent en Parkinson's drug from Biogen, Denali comes up short 2026-05-22T14:46:00Z Blog https://pharminent.com/kelun-merck-validate-trop2-keytruda-pairing-in-lung-cancer-with-improved-survival/ 2026-05-22T16:17:07Z Pharminent en Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival 2026-05-22T14:04:07Z Blog https://pharminent.com/gilead-inks-140m-api-supply-deal-tightening-ties-to-korean-manufacturer/ 2026-05-22T16:17:08Z Pharminent en Gilead inks $140M API supply deal, tightening ties to Korean manufacturer 2026-05-22T12:09:36Z Blog https://pharminent.com/gbl-joins-cvc-in-10-7bn-takeover-bid-for-recordati/ 2026-05-22T16:17:09Z Pharminent en GBL joins CVC in 10.7bn takeover bid for Recordati 2026-05-22T10:37:57Z Blog https://pharminent.com/gilead-sciences-completes-tubulis-acquisition-for-5bn/ 2026-05-22T16:17:09Z Pharminent en Gilead Sciences completes Tubulis acquisition for $5bn 2026-05-22T10:19:52Z Blog https://pharminent.com/80959-2/ 2026-05-21T23:31:34Z Pharminent en 2026-05-21T23:31:31Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-may-21-2026/ 2026-05-21T23:27:31Z Pharminent en Rare Disease & Gene Therapy Digest • May 21, 2026 2026-05-21T23:27:29Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-21-2026/ 2026-05-21T17:11:21Z Pharminent en Strategic News Watch • May 21, 2026 2026-05-21T17:10:24Z Blog https://pharminent.com/in-alzheimers-bristol-myers-sees-big-promise-beyond-amyloid/ 2026-05-21T15:49:10Z Pharminent en In Alzheimer's, Bristol Myers sees big promise beyond amyloid 2026-05-21T13:00:00Z Blog https://pharminent.com/lillys-triple-agonist-shows-bariatric-surgery-like-weight-loss-results/ 2026-05-21T15:49:43Z Pharminent en Lilly's triple agonist shows bariatric surgery-like weight loss results 2026-05-21T12:55:42Z Blog https://pharminent.com/lillys-triple-g-retatrutide-aces-crucial-obesity-trial/ 2026-05-21T23:22:52Z Pharminent en Lilly's 'triple G' retatrutide aces crucial obesity trial 2026-05-21T12:14:28Z Blog https://pharminent.com/lilly-bms-incyte-strike-deals-to-keep-biopharmas-ai-integration-rolling/ 2026-05-21T15:49:54Z Pharminent en Lilly, BMS, Incyte strike deals to keep biopharma's AI integration rolling 2026-05-21T11:29:44Z Blog https://pharminent.com/biomarin-bounces-back-as-voxzogo-performs-bigger-than-expected-in-new-indication/ 2026-05-21T19:25:52Z Pharminent en BioMarin bounces back as Voxzogo performs 'bigger than expected' in new indication 2026-05-21T11:19:14Z Blog https://pharminent.com/eli-lilly-maintains-ma-streak-with-202m-engage-bio-buyout/ 2026-05-21T15:50:05Z Pharminent en Eli Lilly maintains M&A streak with $202m Engage Bio buyout 2026-05-21T10:22:38Z Blog https://pharminent.com/fujifilm-opens-new-ipsc-facility-in-madison-us-2/ 2026-05-21T23:22:54Z Pharminent en FUJIFILM opens new iPSC facility in Madison, US 2026-05-21T10:04:15Z Blog https://pharminent.com/bayer-gets-swift-review-for-kerendia-in-type-1-diabetes/ 2026-05-21T15:50:14Z Pharminent en Bayer gets swift review for Kerendia in type 1 diabetes 2026-05-21T09:41:08Z Blog https://pharminent.com/ats-2026-pabpc4-gene-identified-as-a-key-driver-of-emphysema-in-copd/ 2026-05-21T19:25:54Z Pharminent en ATS 2026: PABPC4 gene identified as a key driver of emphysema in COPD 2026-05-21T09:34:40Z Blog https://pharminent.com/ats-2026-long-term-data-show-durable-benefit-of-trikafta-for-cystic-fibrosis/ 2026-05-21T15:50:35Z Pharminent en ATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosis 2026-05-21T09:30:18Z Blog https://pharminent.com/80900-2/ 2026-05-20T23:55:49Z Pharminent en 2026-05-20T23:55:43Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-may-20-2026/ 2026-05-20T23:41:55Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • May 20, 2026 2026-05-20T23:41:40Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-may-20-2026/ 2026-05-20T19:13:55Z Pharminent en Manufacturing Intelligence • Weekly Digest • May 20, 2026 2026-05-20T19:13:48Z Blog https://pharminent.com/remepys-hybrid-parkinsons-therapy-poised-for-phase-3/ 2026-05-21T15:51:00Z Pharminent en Remepy's hybrid Parkinson's therapy poised for phase 3 2026-05-20T19:11:27Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-20-2026/ 2026-05-20T17:23:37Z Pharminent en Strategic News Watch • May 20, 2026 2026-05-20T17:23:17Z Blog https://pharminent.com/immunovants-potential-autoimmune-blockbuster-waves-rna-editing-update/ 2026-05-20T15:55:07Z Pharminent en Immunovant's potential autoimmune 'blockbuster'; Wave's RNA editing update 2026-05-20T14:43:50Z Blog https://pharminent.com/pazdur-declines-to-announce-candidacy-for-vacated-fda-commissioner-role/ 2026-05-20T15:55:27Z Pharminent en Pazdur declines to announce candidacy for vacated FDA commissioner role 2026-05-20T14:32:30Z Blog https://pharminent.com/pepaxti-study-supports-use-in-wider-myeloma-population/ 2026-05-21T23:22:54Z Pharminent en Pepaxti study supports use in wider myeloma population 2026-05-20T11:46:42Z Blog https://pharminent.com/beam-one-ups-wave-as-both-show-promise-of-genetic-editing-for-aatd/ 2026-05-21T19:25:55Z Pharminent en Beam one-ups Wave as both show promise of genetic editing for AATD 2026-05-20T11:41:41Z Blog https://pharminent.com/parabilis-follows-hefty-regeneron-deal-with-ipo-push/ 2026-05-21T23:22:55Z Pharminent en Parabilis follows hefty Regeneron deal with IPO push 2026-05-20T11:39:00Z Blog https://pharminent.com/abbvies-new-immunology-standard-bearer-skyrizi-kneels-to-ucbs-bimzelx-in-psoriatic-arthritis/ 2026-05-21T19:25:55Z Pharminent en AbbVie's new immunology standard-bearer Skyrizi kneels to UCB's Bimzelx in psoriatic arthritis 2026-05-20T11:25:32Z Blog https://pharminent.com/gho-cbc-merge-to-create-largest-healthcare-investment-firm/ 2026-05-21T23:22:56Z Pharminent en GHO, CBC merge to create largest healthcare investment firm 2026-05-20T09:17:40Z Blog